Correlation Between Entrada Therapeutics and China Resources

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Entrada Therapeutics and China Resources at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entrada Therapeutics and China Resources into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entrada Therapeutics and China Resources Power, you can compare the effects of market volatilities on Entrada Therapeutics and China Resources and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entrada Therapeutics with a short position of China Resources. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entrada Therapeutics and China Resources.

Diversification Opportunities for Entrada Therapeutics and China Resources

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Entrada and China is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Entrada Therapeutics and China Resources Power in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Resources Power and Entrada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entrada Therapeutics are associated (or correlated) with China Resources. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Resources Power has no effect on the direction of Entrada Therapeutics i.e., Entrada Therapeutics and China Resources go up and down completely randomly.

Pair Corralation between Entrada Therapeutics and China Resources

If you would invest  1,600  in Entrada Therapeutics on October 1, 2024 and sell it today you would earn a total of  141.00  from holding Entrada Therapeutics or generate 8.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Entrada Therapeutics  vs.  China Resources Power

 Performance 
       Timeline  
Entrada Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
China Resources Power 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China Resources Power has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward-looking indicators, China Resources is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Entrada Therapeutics and China Resources Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Entrada Therapeutics and China Resources

The main advantage of trading using opposite Entrada Therapeutics and China Resources positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entrada Therapeutics position performs unexpectedly, China Resources can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Resources will offset losses from the drop in China Resources' long position.
The idea behind Entrada Therapeutics and China Resources Power pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated